{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T21:34:42Z","timestamp":1780349682007,"version":"3.54.1"},"reference-count":125,"publisher":"Elsevier","isbn-type":[{"value":"9780443137297","type":"print"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/bs.irn.2023.08.010","type":"book-chapter","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T02:13:58Z","timestamp":1694484838000},"page":"43-65","source":"Crossref","is-referenced-by-count":7,"title":["A review of the use of psychotropic medication to address challenging behaviour in neurodevelopmental disorders"],"prefix":"10.1016","author":[{"given":"Maria G.","family":"Valdovinos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Epperson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6104-7329","authenticated-orcid":false,"given":"Carissa","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.irn.2023.08.010_bib1","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s10803-019-04291-8","article-title":"Psychotropic medication prescribing for neuropsychiatric comorbidities in individuals diagnosed with autism spectrum disorder (ASD) in the UK","volume":"50","author":"Alfageh","year":"2020","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"10.1016\/bs.irn.2023.08.010_bib2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2788.2012.01562.x","article-title":"Emotional and behavioral problems in children with visual impairment, intellectual and multiple disabilities","volume":"57","author":"Alimovic","year":"2013","journal-title":"Journal of Intellectual Disability Research"},{"key":"10.1016\/bs.irn.2023.08.010_bib3","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2788.2006.00877.x","article-title":"Predictors, cost and characteristics of out of area placement for people with intellectual disability and challenging behavior","volume":"51","author":"Allen","year":"2007","journal-title":"Journal of Intellectual Disability Research"},{"issue":"2","key":"10.1016\/bs.irn.2023.08.010_bib4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/1044546041649020","article-title":"Risperidone effects in the presence\/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ","volume":"14","author":"Aman","year":"2004","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1016\/bs.irn.2023.08.010_bib5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1136\/pmj.79.929.139","article-title":"Psychopharmacological treatments in persons with dual diagnosis of psychiatric disorders and developmental disabilities","volume":"79","author":"Antochi","year":"2003","journal-title":"Postgraduate Medical Journal"},{"key":"10.1016\/bs.irn.2023.08.010_bib6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-2788.2010.01337.x","article-title":"The prevalence and phenomenology of self-injurious and aggressive behavior in genetic syndromes","volume":"55","author":"Arron","year":"2011","journal-title":"Journal of Intellectual Disability Research"},{"key":"10.1016\/bs.irn.2023.08.010_bib7","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1046\/j.1365-2788.2003.00507.x","article-title":"Risk fasters for self-injurious behaviors among 222 young children with autistic disorders","volume":"47","author":"Baghdadli","year":"2003","journal-title":"Journal of Intellectual Disability Research"},{"issue":"1","key":"10.1016\/bs.irn.2023.08.010_bib8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/mrdd.20007","article-title":"Psychopharmacology in fragile X syndrome? Present and future","volume":"10","author":"Berry-Kravis","year":"2004","journal-title":"Mental Retardation and Developmental Disabilities Research Reviews"},{"key":"10.1016\/bs.irn.2023.08.010_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/843016","article-title":"Clinic-based retrospective analysis of psychopharmacology for behavior in fragile X syndrome","volume":"2012","author":"Berry-Kravis","year":"2012","journal-title":"International Journal of Pediatrics"},{"issue":"4","key":"10.1016\/bs.irn.2023.08.010_bib10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/DBP.0b013e31817dc447","article-title":"Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome","volume":"29","author":"Berry-Kravis","year":"2008","journal-title":"Journal of Developmental and Behavioral Pediatrics"},{"key":"10.1016\/bs.irn.2023.08.010_bib11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ridd.2017.02.003","article-title":"What worries parents of a child with autism? Evidence from a biomarker for chronic stress","volume":"62","author":"Bitsika","year":"2017","journal-title":"Research in Developmental Disabilities"},{"key":"10.1016\/bs.irn.2023.08.010_bib12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/bjc.12118","article-title":"Challenging behaviors in adults with an intellectual disability: A total population study and exploration of risk indices","volume":"56","author":"Bowring","year":"2017","journal-title":"British Journal of Clinical Psychology"},{"issue":"1","key":"10.1016\/bs.irn.2023.08.010_bib13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1345\/aph.1K427","article-title":"Buspirone for autistic disorder in a woman with an intellectual disability","volume":"42","author":"Brahm","year":"2008","journal-title":"The Annals of Pharmacotherapy"},{"issue":"4","key":"10.1016\/bs.irn.2023.08.010_bib14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1352\/1944-7558-125.4.247","article-title":"Examining the specificity of forms and functions of aggressive behavior in boys with fragile X syndrome","volume":"125","author":"Britton","year":"2020","journal-title":"American Journal on Intellectual and Developmental Disabilities"},{"issue":"1","key":"10.1016\/bs.irn.2023.08.010_bib15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pediatrneurol.2012.04.002","article-title":"Levetiracetam-induced reversible autistic regression","volume":"47","author":"Camacho","year":"2012","journal-title":"Pediatric Neurology"},{"issue":"45\u201353","key":"10.1016\/bs.irn.2023.08.010_bib16","article-title":"Efficacy of low-dose buspirone for restricted and repetitive behavior in young children with autism spectrum disorder: A randomized trial","volume":"170","author":"Chugani","year":"2016","journal-title":"The Journal of Pediatrics"},{"issue":"5","key":"10.1016\/bs.irn.2023.08.010_bib17","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s10803-009-0908-z","article-title":"A large-scale study of the psychometric characteristics of the IBR modified overt aggression scale: Findings and evidence for increased self-destructive behaviors in adult females with autism spectrum disorder","volume":"40","author":"Cohen","year":"2010","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"10.1016\/bs.irn.2023.08.010_bib18","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1365-2788.2008.01060.x","article-title":"Adults with intellectual disabilities: Prevalence, incidence and remission of self-injurious behavior, and related factors","volume":"53","author":"Cooper","year":"2009","journal-title":"Journal of Intellectual Disability Research"},{"issue":"1","key":"10.1016\/bs.irn.2023.08.010_bib19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11689-010-9067-y","article-title":"Clinical assessment of DSM-IV anxiety disorders in fragile X syndrome: Prevalence and characterization","volume":"3","author":"Cordeiro","year":"2011","journal-title":"Journal of Neurodevelopmental Disorders"},{"issue":"1","key":"10.1016\/bs.irn.2023.08.010_bib20","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1080\/07853890.2022.2121853","article-title":"Management of psychotropic medications in adults with intellectual disability: A scoping review","volume":"54","author":"Costelloa","year":"2022","journal-title":"Annals of Medicine"},{"issue":"4","key":"10.1016\/bs.irn.2023.08.010_bib21","first-page":"1","article-title":"Interactions between behavior function and psychotropic medication","volume":"48","author":"Cox","year":"2015","journal-title":"Journal of Applied Behavior Analysis"},{"issue":"1","key":"10.1016\/bs.irn.2023.08.010_bib22","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/jaba.873","article-title":"Long\u2010term functional stability of problem behavior exposed to psychotropic medications","volume":"55","author":"Cox","year":"2022","journal-title":"Journal of Applied Behavior Analysis"},{"key":"10.1016\/bs.irn.2023.08.010_bib23","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1007\/s10803-019-04002-3","article-title":"The persistence of self-injurious and aggressive behavior in males with Fragile X Syndrome over 8 years: A longitudinal study of prevalence and predictive risk markers","volume":"49","author":"Crawford","year":"2019","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"10.1016\/bs.irn.2023.08.010_bib24","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1365-2788.2006.00815.x","article-title":"Prevalence and types of aggressive behavior among adults with intellectual disabilities","volume":"50","author":"Crocker","year":"2006","journal-title":"Journal of Intellectual Disability Research"},{"key":"10.1016\/bs.irn.2023.08.010_bib25","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1023\/A:1024402500425","article-title":"Use of functional analysis methodology in the evaluation of medication effects","volume":"33","author":"Crosland","year":"2003","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"10.1016\/bs.irn.2023.08.010_bib26","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.ridd.2012.10.004","article-title":"The age-related prevalence of aggression and self-injury in persons with an intellectual disability: A review","volume":"34","author":"Davies","year":"2012","journal-title":"Research in Developmental Disabilities"},{"key":"10.1016\/bs.irn.2023.08.010_bib27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ridd.2015.12.003","article-title":"Self-injury, aggression and destruction in children with severe intellectual disability: Incidence, persistence and novel, predictive behavioral risk markers","volume":"49\u201350","author":"Davies","year":"2016","journal-title":"Research in Developmental Disabilities"},{"issue":"Pt 2","key":"10.1016\/bs.irn.2023.08.010_bib28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2788.2007.00965.x","article-title":"The effectiveness of mood stabilizers and antiepileptic medication for the management of behaviour problems in adults with intellectual disability: A systematic review","volume":"52","author":"Deb","year":"2008","journal-title":"Journal of Intellectual Disability Research"},{"issue":"5","key":"10.1016\/bs.irn.2023.08.010_bib29","doi-asserted-by":"crossref","DOI":"10.1192\/bjo.2020.97","article-title":"UK psychiatrists\u2019 experience of withdrawal of antipsychotics prescribed for challenging behaviours in adults with intellectual disabilities and\/or autism","volume":"6","author":"Deb","year":"2020","journal-title":"BJPsych open"},{"key":"10.1016\/bs.irn.2023.08.010_bib30","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/YCO.0b013e3282ab9952","article-title":"Psychotropic medication for behaviour problems in people with intellectual disability: A review of the current literature","volume":"20","author":"Deb","year":"2007","journal-title":"Current Opinion in Psychiatry"},{"key":"10.1016\/bs.irn.2023.08.010_bib31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/jir.12119","article-title":"Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour","volume":"59","author":"Deb","year":"2015","journal-title":"Journal of Intellectual Disability Research"},{"issue":"5","key":"10.1016\/bs.irn.2023.08.010_bib32","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1469-7610.2006.01712.x","article-title":"Developmental course of psychopathology in youths with and without intellectual disabilities","volume":"48","author":"de Ruiter","year":"2007","journal-title":"Journal of Child Psychology and Psychiatry"},{"key":"10.1016\/bs.irn.2023.08.010_bib33","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1365-2788.2010.01288.x","article-title":"Attachment behavior towards support staff in young people with intellectual disabilities: Associations with challenging behavior","volume":"54","author":"De Schipper","year":"2010","journal-title":"Journal of Intellectual Disability Research"},{"key":"10.1016\/bs.irn.2023.08.010_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpr.2022.102158","article-title":"A systematic review of risk for the development and persistence of self-injurious behavior in intellectual and developmental disabilities","volume":"94","author":"Dimian","year":"2022","journal-title":"Clinical Psychology Review"},{"issue":"4","key":"10.1016\/bs.irn.2023.08.010_bib35","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1089\/cap.2017.0057","article-title":"Risperidone treatment for irritability in fragile X syndrome","volume":"28","author":"Dominick","year":"2018","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"5","key":"10.1016\/bs.irn.2023.08.010_bib36","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s10803-012-1661-2","article-title":"Brief report: Retrospective case series of oxcarbazepine for irritability\/agitation symptoms in autism spectrum disorder","volume":"43","author":"Douglas","year":"2013","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"10.1016\/bs.irn.2023.08.010_bib37","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1007\/s10803-012-1497-9","article-title":"Risk factors associated with self-injurious behaviors in children and adolescents with autism spectrum disorders","volume":"42","author":"Duerden","year":"2012","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"10.1016\/bs.irn.2023.08.010_bib38","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ridd.2016.08.006","article-title":"Prevalence and putative risk markers of challenging behavior in students with intellectual disabilities","volume":"96","author":"Dworschak","year":"2016","journal-title":"Research in Developmental Disabilities"},{"issue":"11","key":"10.1016\/bs.irn.2023.08.010_bib39","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1007\/s10803-019-04173-z","article-title":"Pharmacologic interventions for irritability, aggression, agitation and self-injurious behavior in fragile X syndrome: An initial cross-sectional analysis","volume":"49","author":"Eckert","year":"2019","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"10.1016\/bs.irn.2023.08.010_bib40","doi-asserted-by":"crossref","DOI":"10.1177\/17446295221134420","article-title":"Adverse events and contradictory effects of benzodiazepine in a case with intellectual disability and challenging behaviour","author":"Elbing","year":"2022","journal-title":"Journal of Intellectual Disabilities"},{"key":"10.1016\/bs.irn.2023.08.010_bib41","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.1365-2788.2003.00464.x","article-title":"Prevalence of psychiatric disorders in children and adolescents with and without intellectual disability","volume":"47","author":"Emerson","year":"2003","journal-title":"Journal of Intellectual Disability Research"},{"key":"10.1016\/bs.irn.2023.08.010_bib42","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1365-2788.1995.tb00543.x","article-title":"The form and function of challenging behaviors","volume":"39","author":"Emerson","year":"1995","journal-title":"Journal of Intellectual Disability Research"},{"key":"10.1016\/bs.irn.2023.08.010_bib43","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0891-4222(00)00061-5","article-title":"The prevalence of challenging behaviors: A total population study","volume":"22","author":"Emerson","year":"2001","journal-title":"Research in Developmental Disabilities"},{"key":"10.1016\/bs.irn.2023.08.010_bib44","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s10803-009-0750-3","article-title":"A longitudinal investigation of psychotropic and non-psychotropic medication use among adolescents and adults with autism spectrum disorders","volume":"39","author":"Esbensen","year":"2009","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"10.1016\/bs.irn.2023.08.010_bib45","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1007\/s10803-019-03903-7","article-title":"Psychotropic medication use for adults with autism spectrum disorder who receive services and supports through adult developmental disability services in the United States","volume":"49","author":"Esler","year":"2019","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"4","key":"10.1016\/bs.irn.2023.08.010_bib46","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/bin.1823","article-title":"Further analysis of psychotropic medication and challenging behavior","volume":"36","author":"Falligant","year":"2021","journal-title":"Behavioral Interventions"},{"issue":"3","key":"10.1016\/bs.irn.2023.08.010_bib47","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/1362361313518995","article-title":"Aggression in children with autism spectrum disorders and a clinic referred comparison group","volume":"19","author":"Farmer","year":"2015","journal-title":"Autism: The International Journal of Research and Practice"},{"key":"10.1016\/bs.irn.2023.08.010_bib48","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1365-2788.2011.01524.x","article-title":"Investigating low adaptive behavior and presence of the triad of impairments characteristic of autism spectrum disorder as indicators of risk for challenging behavior among adults with intellectual disabilities","volume":"57","author":"Felce","year":"2013","journal-title":"Journal of Intellectual Disability Research"},{"issue":"4","key":"10.1016\/bs.irn.2023.08.010_bib49","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00004583-200004000-00021","article-title":"A double-blind pilot study of risperidone in the treatment of conduct disorder","volume":"39","author":"Findling","year":"2000","journal-title":"Journal of the American Academy of Child & Adolescent Psychiatry"},{"key":"10.1016\/bs.irn.2023.08.010_bib50","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.2147\/NDT.S84585","article-title":"Aggression in autism spectrum disorder: Presentation and treatment options","volume":"12","author":"Fitzpatrick","year":"2016","journal-title":"Neuropsychiatric Disease and Treatment"},{"key":"10.1016\/bs.irn.2023.08.010_bib51","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/jir.12487","article-title":"Risk factors and topographies for self-injurious behavior in a sample of adults with intellectual developmental disorders","volume":"62","author":"Folch","year":"2018","journal-title":"Journal of Intellectual Disability Research"},{"key":"10.1016\/bs.irn.2023.08.010_bib52","series-title":"Self-injurious behavior in individuals with neurodevelopmental conditions","first-page":"19","article-title":"Phenomenology and natural history of self-injurious behavior","author":"Furniss","year":"2019"},{"key":"10.1016\/bs.irn.2023.08.010_bib53","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ridd.2015.08.006","article-title":"Behavioral and emotional profile and parental stress in preschool children with autism spectrum disorder","volume":"45\u201346","author":"Giovagnoli","year":"2015","journal-title":"Research in Developmental Disabilities"},{"issue":"1","key":"10.1016\/bs.irn.2023.08.010_bib54","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/20473869.2016.1221233","article-title":"Challening behavior, functioning difficulties, and quality of life of adults with intellectual disabilities","volume":"64","author":"Gur","year":"2018","journal-title":"International Journal of Developmental Disabilities"},{"issue":"1","key":"10.1016\/bs.irn.2023.08.010_bib55","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1542\/peds.2008-0317","article-title":"Advances in the treatment of fragile X syndrome","volume":"123","author":"Hagerman","year":"2009","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/bs.irn.2023.08.010_bib56","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/02739615.2021.1987237","article-title":"A neurobehavioral continuum of care for individuals with intellectual and developmental disabilities with severe problem behavior","volume":"52","author":"Hagopian","year":"2022","journal-title":"Children\u2019s Health Care"},{"issue":"3","key":"10.1016\/bs.irn.2023.08.010_bib57","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/CHI.0b013e318195bd15","article-title":"Physiological correlates of social avoidance behavior in children and adolescents with fragile X syndrome","volume":"48","author":"Hall","year":"2009","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1016\/bs.irn.2023.08.010_bib58","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ridd.2018.02.020","article-title":"How common are challenging behaviors amongst individuals with Fragile X Syndrome? A systematic review","volume":"76","author":"Hardiman","year":"2018","journal-title":"Research in Developmental Disabilities"},{"issue":"3","key":"10.1016\/bs.irn.2023.08.010_bib59","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1089\/cap.2012.0012","article-title":"Long-term treatment with atomoxetine for attention-deficit\/hyperactivity disorder symptoms in children and adolescents with autism spectrum disorder: An open-label extension study","volume":"23","author":"Harfterkamp","year":"2013","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1016\/bs.irn.2023.08.010_bib60","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1365-2788.2008.01065.x","article-title":"Prevalence and risk factors of maladaptive behavior in young children with autistic disorder","volume":"52","author":"Hartley","year":"2008","journal-title":"Journal of Intellectual Disability Research"},{"issue":"8","key":"10.1016\/bs.irn.2023.08.010_bib61","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/dev.20551","article-title":"Autonomic regulation in fragile x syndrome","volume":"53","author":"Heilman","year":"2011","journal-title":"Developmental Psychobiology"},{"key":"10.1016\/bs.irn.2023.08.010_bib62","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s10803-007-0365-5","article-title":"Brief report: Aggression and stereotypic behavior in males with fragile x syndrome \u2013 Moderating secondary genes in a \u201csingle gene\u201d disorder","volume":"38","author":"Hessl","year":"2008","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"4","key":"10.1016\/bs.irn.2023.08.010_bib63","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1007\/s10803-013-1952-2","article-title":"Antiepileptic medications in autism spectrum disorder: A systematic review and meta-analysis","volume":"44","author":"Hirota","year":"2014","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"7","key":"10.1016\/bs.irn.2023.08.010_bib64","doi-asserted-by":"crossref","first-page":"530","DOI":"10.4088\/JCP.v62n07a05","article-title":"An open trial of Divalproex sodium in autism spectrum disorders","volume":"62","author":"Hollander","year":"2001","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"3","key":"10.1016\/bs.irn.2023.08.010_bib65","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1176\/appi.ajp.2011.10050764","article-title":"A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders","volume":"169","author":"Hollander","year":"2012","journal-title":"The American Journal of Psychiatry"},{"issue":"1","key":"10.1016\/bs.irn.2023.08.010_bib66","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1017\/S146114570400481X","article-title":"Serotonergic antidepressant effects on aggressive, self-injurious and destructive\/disruptive behaviours in intellectually disabled adults: A retrospective, open-label, Naturalistic Trial","volume":"8","author":"Janowsky","year":"2005","journal-title":"The International Journal of Neuropsychopharmacology"},{"key":"10.1016\/bs.irn.2023.08.010_bib67","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/acps.12644","article-title":"Use of psychotropic drugs in patients with autism spectrum disorders: A systematic review","volume":"135","author":"Jobski","year":"2017","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"2","key":"10.1016\/bs.irn.2023.08.010_bib68","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1089\/cap.2005.15.325","article-title":"Retrospective assessment of Atomoxetine in children and adolescents with pervasive developmental disorders","volume":"15","author":"Jou","year":"2005","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"3","key":"10.1016\/bs.irn.2023.08.010_bib69","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1023\/A:1024466819989","article-title":"Brief report: Clonazepam behavioral side effects with an individual with mental retardation","volume":"33","author":"Kalachnik","year":"2003","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"10.1016\/bs.irn.2023.08.010_bib70","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1007\/s10803-010-1118-4","article-title":"Aggression in children and adolescents with ASD: Prevalence and risk factors","volume":"41","author":"Kanne","year":"2011","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"3","key":"10.1016\/bs.irn.2023.08.010_bib71","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1468-3148.1996.tb00108.x","article-title":"Persistence and change in challenging and problem behaviors of young adults with intellectual disability living in the family home","volume":"9","author":"Kiernan","year":"1996","journal-title":"Journal of Applied Research in Intellectual Disabilities"},{"issue":"6","key":"10.1016\/bs.irn.2023.08.010_bib72","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1001\/archgenpsychiatry.2009.30","article-title":"Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: Citalopram ineffective in children with autism","volume":"66","author":"King","year":"2009","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1016\/bs.irn.2023.08.010_bib73","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4088\/JCP.v67n0311","article-title":"Selective serotonin reuptake inhibitors in autism: A review of efficacy and tolerability","volume":"67","author":"Kolevzon","year":"2006","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"6","key":"10.1016\/bs.irn.2023.08.010_bib74","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1108\/AMHID-06-2015-0029","article-title":"Predictors of challenging behavior in adults with intellectual disability","volume":"9","author":"Koritsas","year":"2015","journal-title":"Advances in Mental Health and Intellectual Disabilities"},{"issue":"3","key":"10.1016\/bs.irn.2023.08.010_bib75","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.pcl.2020.02.005","article-title":"Behavioral approaches to assessment and early intervention for severe problem behavior in intellectual and developmental disabilities","volume":"67","author":"Kurtz","year":"2020","journal-title":"Pediatric Clinics of North America"},{"issue":"2","key":"10.1016\/bs.irn.2023.08.010_bib76","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/jir.12433","article-title":"Medication use by adolescents and adults with fragile X syndrome","volume":"62","author":"Laxman","year":"2018","journal-title":"Journal of Intellectual Disability Research"},{"key":"10.1016\/bs.irn.2023.08.010_bib77","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s10803-006-0147-5","article-title":"Behavioral and emotional problems in young people with pervasive developmental disorders: Relative prevalence, effects of subject characteristics, and empirical classification","volume":"36","author":"Lecavalier","year":"2006","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"3","key":"10.1016\/bs.irn.2023.08.010_bib78","first-page":"74","article-title":"Anticonvulsant use in the treatment of bipolar disorder: A primer for primary care physicians","volume":"1","author":"Leo","year":"1999","journal-title":"Primary Care Companion to the Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1016\/bs.irn.2023.08.010_bib79","doi-asserted-by":"crossref","first-page":"E299","DOI":"10.1503\/jpn.210191","article-title":"Therapeutic effects of antidepressants for global improvement and subdomain symptoms of autism spectrum disorder: A systematic review and meta-analysis","volume":"47","author":"Liang","year":"2022","journal-title":"Journal of Psychiatry and Neuroscience"},{"issue":"2","key":"10.1016\/bs.irn.2023.08.010_bib80","doi-asserted-by":"crossref","DOI":"10.1192\/bjo.2022.18","article-title":"Randomised controlled trials of mood stabilisers for people with autism spectrum disorder: Systematic review and meta-analysis","volume":"8","author":"Limbu","year":"2022","journal-title":"BJPsych Open"},{"key":"10.1016\/bs.irn.2023.08.010_bib81","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1365-2788.2006.00948.x","article-title":"Challenging behaviors: Prevalence and topographies","volume":"51","author":"Lowe","year":"2007","journal-title":"Journal of Intellectual Disability Research"},{"key":"10.1016\/bs.irn.2023.08.010_bib82","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.ridd.2013.01.010","article-title":"Prevalence and risk markers of behavioral problems among adults with intellectual disabilities: A total population study in Orebro County, Sweden","volume":"34","author":"Lundqvist","year":"2013","journal-title":"Research in Developmental Disabilities"},{"issue":"8","key":"10.1016\/bs.irn.2023.08.010_bib83","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1176\/appi.ps.52.8.1105","article-title":"Fluvoxamine and aggression in mental retardation","volume":"52","author":"La Malfa","year":"2001","journal-title":"Psychiatric Services"},{"key":"10.1016\/bs.irn.2023.08.010_bib84","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s10803-007-0481-2","article-title":"Psychiatric hospitalization among children with autism spectrum disorders","volume":"38","author":"Mandell","year":"2008","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"11","key":"10.1016\/bs.irn.2023.08.010_bib85","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1097\/CHI.0b013e3181b76658","article-title":"A placebo-controlled, fixed-dose study of Aripiprazole in children and adolescents with irritability associated with autistic disorder","volume":"48","author":"Marcus","year":"2009","journal-title":"Journal of the American Academy of Child & Adolescent Psychiatry"},{"key":"10.1016\/bs.irn.2023.08.010_bib86","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1016\/j.ridd.2014.08.004","article-title":"Assessing aggression in persons with autism spectrum disorders: An overview","volume":"35","author":"Matson","year":"2014","journal-title":"Research in Developmental Disabilities"},{"issue":"4","key":"10.1016\/bs.irn.2023.08.010_bib87","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/13668250802492600","article-title":"Characteristics of challenging behaviors in adults with autistic disorder, PDD-NOS, and intellectual disability","volume":"33","author":"Matson","year":"2008","journal-title":"Journal of Intellectual and Developmental Disability"},{"issue":"5","key":"10.1016\/bs.irn.2023.08.010_bib88","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJMoa013171","article-title":"Risperidone in children with autism and serious behavioral problems","volume":"347","author":"McCracken","year":"2002","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"10.1016\/bs.irn.2023.08.010_bib89","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/archpsyc.1996.01830110037005","article-title":"A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder","volume":"53","author":"McDougle","year":"1996","journal-title":"Archives of General Psychiatry"},{"issue":"1","key":"10.1016\/bs.irn.2023.08.010_bib90","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1901\/jeab.1982.37-149","article-title":"Distinguishing between discriminative and motivational functions of stimuli","volume":"37","author":"Michael","year":"1982","journal-title":"Journal of the Experimental Analysis of Behavior"},{"key":"10.1016\/bs.irn.2023.08.010_bib91","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s10803-014-2307-3","article-title":"Multidisciplinary assessment and treatment of self-injurious behavior in autism spectrum disorder and intellectual disability: Integration of psychological and biological theory approach","volume":"45","author":"Minshawi","year":"2015","journal-title":"Journal of Autism and Development Disorders"},{"issue":"2","key":"10.1016\/bs.irn.2023.08.010_bib92","first-page":"28","article-title":"Revisiting lithium: Utility for behavioral stabilization in adolescents and adults with autism spectrum disorder","volume":"49","author":"Mintz","year":"2019","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1016\/bs.irn.2023.08.010_bib93","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ridd.2007.06.002","article-title":"Psychiatric disorders and behavioral problems in people with intellectual disability","volume":"29","author":"Myrbakk","year":"2008","journal-title":"Research in Developmental Disabilities"},{"issue":"5","key":"10.1016\/bs.irn.2023.08.010_bib94","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/hup.491","article-title":"Tianeptine: A novel strategy of psychopharmacological treatment of children with autistic disorder","volume":"18","author":"Niederhofer","year":"2003","journal-title":"Human Psychopharmacology: Clinical and Experimental"},{"issue":"6","key":"10.1016\/bs.irn.2023.08.010_bib95","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1542\/peds.2008-3782","article-title":"Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder","volume":"124","author":"Owen","year":"2009","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/bs.irn.2023.08.010_bib96","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10803-006-0234-7","article-title":"Risperidone improves behavioral symptoms in children with autism in a randomized, double-blind, placebo-controlled trial","volume":"37","author":"Pandina","year":"2007","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"5","key":"10.1016\/bs.irn.2023.08.010_bib97","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2788.2011.01484.x","article-title":"Self-injurious behaviour in intellectual disability syndromes: evidence for aberrant pain signalling as a contributing factor","volume":"56","author":"Peebles","year":"2012","journal-title":"Journal of intellectual disability research\u202f: JIDR"},{"key":"10.1016\/bs.irn.2023.08.010_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2021.110326","article-title":"The pediatric psychopharmacology of autism spectrum disorder: A systematic review - Part I: The past and the present","volume":"110","author":"Persico","year":"2021","journal-title":"Progress in Neuro-psychopharmacology & Biological Psychiatry"},{"key":"10.1016\/bs.irn.2023.08.010_bib99","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/jir.12268","article-title":"Risk factors associated with challenging behavior in people with profound intellectual and multiple disabilities","volume":"60","author":"Poppes","year":"2016","journal-title":"Journal of Intellectual Disability Research"},{"key":"10.1016\/bs.irn.2023.08.010_bib100","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.ridd.2010.07.017","article-title":"Frequency and severity of challenging behavior in people with profound intellectual and multiple disabilities","volume":"31","author":"Poppes","year":"2010","journal-title":"Research in Developmental Disabilities"},{"key":"10.1016\/bs.irn.2023.08.010_bib101","doi-asserted-by":"crossref","first-page":"810","DOI":"10.3389\/fpsyt.2019.00810","article-title":"A randomized controlled trial of sertraline in young children with autism spectrum disorder","volume":"10","author":"Potter","year":"2019","journal-title":"Frontiers in Psychiatry"},{"issue":"4","key":"10.1016\/bs.irn.2023.08.010_bib102","first-page":"159","article-title":"Buspirone treatment of aggression and anxiety in mentally retarded patients: A multiple-baseline, placebo lead-in study","volume":"52","author":"Ratey","year":"1991","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1016\/bs.irn.2023.08.010_bib103","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00004714-200108000-00012","article-title":"Clomipramine versus haloperidol in the treatment of autistic disorder: A double-blind, placebo-controlled, crossover study","volume":"21","author":"Remington","year":"2001","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/bs.irn.2023.08.010_bib104","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1365-2788.2012.01537.x","article-title":"Self-injurious behavior in individuals with autism spectrum disorder and intellectual disability","volume":"56","author":"Richards","year":"2012","journal-title":"Journal of Intellectual Disability Research"},{"issue":"2","key":"10.1016\/bs.irn.2023.08.010_bib105","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00004583-199402000-00017","article-title":"Clinical effects of buspirone on intractable self-injury in adults with mental retardation","volume":"33","author":"Ricketts","year":"1994","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"4","key":"10.1016\/bs.irn.2023.08.010_bib106","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1352\/1944-7558-119.4.351","article-title":"Risk factors for self-injury, aggression, and stereotypes behavior among young children at risk for intellectual and developmental disabilities","volume":"119","author":"Schroeder","year":"2014","journal-title":"American Journal on intellectual and Developmental Disabilities"},{"issue":"7","key":"10.1016\/bs.irn.2023.08.010_bib107","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1089\/cap.2014.0019","article-title":"Preliminary investigation of lithium for mood disorder symptoms in children and adolescents with autism spectrum disorder","volume":"24","author":"Siegel","year":"2014","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"9","key":"10.1016\/bs.irn.2023.08.010_bib108","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1097\/00004583-200209000-00002","article-title":"Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage iqs","volume":"41","author":"Snyder","year":"2002","journal-title":"Journal of the American Academy of Child & Adolescent Psychiatry"},{"issue":"Pt 10","key":"10.1016\/bs.irn.2023.08.010_bib109","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1365-2788.2006.00935.x","article-title":"The effectiveness of antidepressant medication in the management of behaviour problems in adults with intellectual disabilities: A systematic review","volume":"51","author":"Sohanpal","year":"2007","journal-title":"Journal of Intellectual Disability Research"},{"key":"10.1016\/bs.irn.2023.08.010_bib110","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1007\/s10803-016-2879-1","article-title":"Brief Report: Prevalence of self-injurious behaviors among children with autism spectrum disorder \u2013 A population-based study","volume":"46","author":"Soke","year":"2016","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"10.1016\/bs.irn.2023.08.010_bib111","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10803-016-2951-x","article-title":"Factors associated with self-injurious behaviors in children with autism spectrum disorder: Findings from two large national samples","volume":"47","author":"Soke","year":"2017","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"10.1016\/bs.irn.2023.08.010_bib112","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1468-3148.2010.00579.x","article-title":"The chronicity of self-injurious behavior: A long-term follow-up of a total population study","volume":"24","author":"Taylor","year":"2011","journal-title":"Journal of Applied Research in Intellectual Disabilities"},{"issue":"5","key":"10.1016\/bs.irn.2023.08.010_bib113","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1159\/000329421","article-title":"The psychiatric presentation of fragile x: Evolution of the diagnosis and treatment of the psychiatric comorbidities of fragile X syndrome","volume":"33","author":"Tranfaglia","year":"2011","journal-title":"Developmental Neuroscience"},{"issue":"11","key":"10.1016\/bs.irn.2023.08.010_bib114","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2165\/00023210-200418110-00001","article-title":"Neuropsychiatric symptoms of fragile X syndrome","volume":"18","author":"Tsiouris","year":"2004","journal-title":"CNS Drugs"},{"key":"10.1016\/bs.irn.2023.08.010_bib115","first-page":"64","article-title":"Changes in the rate of problem behavior associated with the removal of the antipsychotic medication quetiapine","volume":"10","author":"Valdovinos","year":"2007","journal-title":"Mental Health Aspects of Developmental Disabilities"},{"key":"10.1016\/bs.irn.2023.08.010_bib116","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1080\/20473869.2016.1177301","article-title":"Assessing the impact of psychotropic medication changes on challenging behavior of individuals with intellectual disabilities","volume":"62","author":"Valdovinos","year":"2016","journal-title":"International Journal of Developmental Disabilities"},{"key":"10.1016\/bs.irn.2023.08.010_bib117","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF03393182","article-title":"Behavior analytic conceptualization of psychotropic medication side effects","volume":"27","author":"Valdovinos","year":"2004","journal-title":"The Behavior Analyst"},{"key":"10.1016\/bs.irn.2023.08.010_bib118","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/19315860903104807","article-title":"Using analogue functional analysis to measure variations in problem behavior rate and function after psychotropic medication changes: A clinical demonstration","volume":"2","author":"Valdovinos","year":"2009","journal-title":"Journal of Mental Health Research in Intellectual Disabilities"},{"key":"10.1016\/bs.irn.2023.08.010_bib119","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s10882-017-9570-0","article-title":"Adverse side effects of psychotropic medication and challenging behavior: Pilot work assessing impact","volume":"29","author":"Valdovinos","year":"2017","journal-title":"Journal of Developmental and Physical Disabilities"},{"issue":"2","key":"10.1016\/bs.irn.2023.08.010_bib120","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1468-3148.2001.00063.x","article-title":"Cyclothymia or unstable mood disorder? A systematic treatment evaluation with valproic acid","volume":"14","author":"Verhoeven","year":"2001","journal-title":"Journal of Applied Research in Intellectual Disabilities"},{"key":"10.1016\/bs.irn.2023.08.010_bib121","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/jir.12238","article-title":"Aggression in fragile x syndrome","volume":"60","author":"Wheeler","year":"2016","journal-title":"Journal of Intellectual Disability Research"},{"issue":"8","key":"10.1016\/bs.irn.2023.08.010_bib122","first-page":"CD004677","article-title":"Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)","author":"Williams","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/bs.irn.2023.08.010_bib123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/280813","article-title":"Early intervention combined with targeted treatment promotes cognitive and behavioral improvements in young children with Fragile X Syndrome","volume":"2012","author":"Winarni","year":"2012","journal-title":"Case Reports in Genetics"},{"issue":"1","key":"10.1016\/bs.irn.2023.08.010_bib124","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1089\/cap.2015.0123","article-title":"Multiple antipsychotic medication use in autism spectrum disorder","volume":"27","author":"Wink","year":"2017","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1016\/bs.irn.2023.08.010_bib125","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1352\/0895-8017(2004)109<310:EORODB>2.0.CO;2","article-title":"Effects of risperidone on destructive behavior of persons with developmental disabilities: III. Functional analysis","volume":"109","author":"Zarcone","year":"2004","journal-title":"American Journal on Mental Retardation"}],"container-title":["International Review of Neurobiology","Fragile X and Related Autism Spectrum Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774223000879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774223000879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,27]],"date-time":"2024-10-27T22:52:33Z","timestamp":1730069553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774223000879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9780443137297"],"references-count":125,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2023.08.010","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]}}}